nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinnarizine—DRD2—nicotine dependence	0.807	1	CbGaD
Cinnarizine—CACNA1G—Nicotine Activity on Chromaffin Cells—CHRNB4—nicotine dependence	0.0294	0.184	CbGpPWpGaD
Cinnarizine—CACNA1G—Nicotine Activity on Chromaffin Cells—CHRNA3—nicotine dependence	0.0223	0.14	CbGpPWpGaD
Cinnarizine—CACNA1C—Nicotine Activity on Chromaffin Cells—CHRNB4—nicotine dependence	0.0172	0.108	CbGpPWpGaD
Cinnarizine—CACNA1C—Nicotine Activity on Chromaffin Cells—CHRNA3—nicotine dependence	0.0131	0.0819	CbGpPWpGaD
Cinnarizine—CYP2A6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00449	0.0281	CbGpPWpGaD
Cinnarizine—CACNA1S—cardiovascular system—nicotine dependence	0.00433	0.163	CbGeAlD
Cinnarizine—Difenoxin—OPRM1—nicotine dependence	0.00409	0.587	CrCbGaD
Cinnarizine—CYP2B6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00362	0.0227	CbGpPWpGaD
Cinnarizine—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNA6—nicotine dependence	0.00356	0.0223	CbGpPWpGaD
Cinnarizine—CACNA1I—brain—nicotine dependence	0.00301	0.113	CbGeAlD
Cinnarizine—Diphenoxylate—OPRM1—nicotine dependence	0.00288	0.413	CrCbGaD
Cinnarizine—CYP2B6—Fatty acids—CYP2A7—nicotine dependence	0.00283	0.0177	CbGpPWpGaD
Cinnarizine—CYP2A6—Xenobiotics—CYP2A7—nicotine dependence	0.00278	0.0174	CbGpPWpGaD
Cinnarizine—CACNA1H—cardiovascular system—nicotine dependence	0.00275	0.104	CbGeAlD
Cinnarizine—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00252	0.0158	CbGpPWpGaD
Cinnarizine—CYP2C9—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0025	0.0156	CbGpPWpGaD
Cinnarizine—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNA5—nicotine dependence	0.00229	0.0144	CbGpPWpGaD
Cinnarizine—CACNA1D—cardiovascular system—nicotine dependence	0.00227	0.0855	CbGeAlD
Cinnarizine—CYP2B6—Xenobiotics—CYP2A7—nicotine dependence	0.00225	0.0141	CbGpPWpGaD
Cinnarizine—CACNA1C—cardiovascular system—nicotine dependence	0.0021	0.079	CbGeAlD
Cinnarizine—CYP1A1—Xenobiotics—CYP2A7—nicotine dependence	0.00207	0.013	CbGpPWpGaD
Cinnarizine—CACNA1G—brain—nicotine dependence	0.00207	0.0777	CbGeAlD
Cinnarizine—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.00196	0.0123	CbGpPWpGaD
Cinnarizine—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNA3—nicotine dependence	0.00187	0.0117	CbGpPWpGaD
Cinnarizine—HRH4—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00184	0.0116	CbGpPWpGaD
Cinnarizine—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNB2—nicotine dependence	0.00165	0.0103	CbGpPWpGaD
Cinnarizine—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.00156	0.00978	CbGpPWpGaD
Cinnarizine—CYP2C9—Xenobiotics—CYP2A7—nicotine dependence	0.00155	0.0097	CbGpPWpGaD
Cinnarizine—HRH4—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.0015	0.00938	CbGpPWpGaD
Cinnarizine—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNA4—nicotine dependence	0.00149	0.00937	CbGpPWpGaD
Cinnarizine—CACNA1H—brain—nicotine dependence	0.00135	0.0508	CbGeAlD
Cinnarizine—CYP1A2—Xenobiotics—CYP2A7—nicotine dependence	0.00132	0.00829	CbGpPWpGaD
Cinnarizine—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00116	0.00725	CbGpPWpGaD
Cinnarizine—CYP2A6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00114	0.00715	CbGpPWpGaD
Cinnarizine—CACNA1D—brain—nicotine dependence	0.00112	0.042	CbGeAlD
Cinnarizine—CACNA1C—brain—nicotine dependence	0.00103	0.0387	CbGeAlD
Cinnarizine—CYP2B6—cardiovascular system—nicotine dependence	0.00103	0.0386	CbGeAlD
Cinnarizine—CYP2C9—cardiovascular system—nicotine dependence	0.00102	0.0382	CbGeAlD
Cinnarizine—CYP2A6—brain—nicotine dependence	0.001	0.0376	CbGeAlD
Cinnarizine—DRD2—midbrain—nicotine dependence	0.000991	0.0373	CbGeAlD
Cinnarizine—CYP2A6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000937	0.00587	CbGpPWpGaD
Cinnarizine—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000933	0.00585	CbGpPWpGaD
Cinnarizine—CYP2B6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00092	0.00577	CbGpPWpGaD
Cinnarizine—HRH4—GPCR ligand binding—TAS2R16—nicotine dependence	0.000906	0.00568	CbGpPWpGaD
Cinnarizine—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000861	0.0054	CbGpPWpGaD
Cinnarizine—CYP1A1—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00085	0.00533	CbGpPWpGaD
Cinnarizine—HRH1—Monoamine GPCRs—DRD2—nicotine dependence	0.000832	0.00522	CbGpPWpGaD
Cinnarizine—CYP2B6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000756	0.00474	CbGpPWpGaD
Cinnarizine—HRH1—Amine ligand-binding receptors—DRD2—nicotine dependence	0.0007	0.00439	CbGpPWpGaD
Cinnarizine—CYP1A1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000698	0.00438	CbGpPWpGaD
Cinnarizine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000648	0.00406	CbGpPWpGaD
Cinnarizine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000643	0.00403	CbGpPWpGaD
Cinnarizine—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00064	0.00401	CbGpPWpGaD
Cinnarizine—CYP2C9—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000634	0.00398	CbGpPWpGaD
Cinnarizine—HRH4—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000631	0.00396	CbGpPWpGaD
Cinnarizine—DRD2—brain—nicotine dependence	0.000623	0.0234	CbGeAlD
Cinnarizine—DRD2—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000578	0.00363	CbGpPWpGaD
Cinnarizine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000549	0.00344	CbGpPWpGaD
Cinnarizine—CYP1A2—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000542	0.0034	CbGpPWpGaD
Cinnarizine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000525	0.00329	CbGpPWpGaD
Cinnarizine—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000521	0.00327	CbGpPWpGaD
Cinnarizine—CYP1A1—brain—nicotine dependence	0.000518	0.0195	CbGeAlD
Cinnarizine—HRH4—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000512	0.00321	CbGpPWpGaD
Cinnarizine—CYP2B6—brain—nicotine dependence	0.000504	0.0189	CbGeAlD
Cinnarizine—HRH4—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000502	0.00314	CbGpPWpGaD
Cinnarizine—CYP2A6—Biological oxidations—CYP2A7—nicotine dependence	0.000498	0.00312	CbGpPWpGaD
Cinnarizine—HRH1—brain—nicotine dependence	0.000492	0.0185	CbGeAlD
Cinnarizine—HRH4—Signaling by GPCR—TAS2R16—nicotine dependence	0.000465	0.00292	CbGpPWpGaD
Cinnarizine—HRH4—G alpha (i) signalling events—DRD2—nicotine dependence	0.000456	0.00286	CbGpPWpGaD
Cinnarizine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000445	0.00279	CbGpPWpGaD
Cinnarizine—CYP2B6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000426	0.00267	CbGpPWpGaD
Cinnarizine—HRH4—GPCR downstream signaling—FGD1—nicotine dependence	0.000402	0.00252	CbGpPWpGaD
Cinnarizine—CYP2B6—Biological oxidations—CYP2A7—nicotine dependence	0.000402	0.00252	CbGpPWpGaD
Cinnarizine—CYP2B6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000396	0.00248	CbGpPWpGaD
Cinnarizine—CYP1A1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000393	0.00247	CbGpPWpGaD
Cinnarizine—HRH4—GPCR ligand binding—OPRM1—nicotine dependence	0.000382	0.00239	CbGpPWpGaD
Cinnarizine—CYP2D6—brain—nicotine dependence	0.000374	0.0141	CbGeAlD
Cinnarizine—CYP1A1—Biological oxidations—CYP2A7—nicotine dependence	0.000371	0.00232	CbGpPWpGaD
Cinnarizine—CYP1A1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000366	0.00229	CbGpPWpGaD
Cinnarizine—HRH4—Signaling by GPCR—FGD1—nicotine dependence	0.000365	0.00229	CbGpPWpGaD
Cinnarizine—HRH4—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000363	0.00227	CbGpPWpGaD
Cinnarizine—DRD2—GPCR ligand binding—TAS2R16—nicotine dependence	0.00035	0.0022	CbGpPWpGaD
Cinnarizine—HRH1—GPCR ligand binding—TAS2R16—nicotine dependence	0.000344	0.00216	CbGpPWpGaD
Cinnarizine—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000296	0.00186	CbGpPWpGaD
Cinnarizine—CYP2C9—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000294	0.00184	CbGpPWpGaD
Cinnarizine—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.000279	0.00175	CbGpPWpGaD
Cinnarizine—CYP2C9—Biological oxidations—CYP2A7—nicotine dependence	0.000277	0.00173	CbGpPWpGaD
Cinnarizine—HRH4—GPCR ligand binding—DRD2—nicotine dependence	0.000276	0.00173	CbGpPWpGaD
Cinnarizine—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000275	0.00173	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—TAS2R16—nicotine dependence	0.000275	0.00172	CbGpPWpGaD
Cinnarizine—CYP2C9—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000273	0.00171	CbGpPWpGaD
Cinnarizine—DRD2—Circadian rythm related genes—CHRNB2—nicotine dependence	0.00027	0.00169	CbGpPWpGaD
Cinnarizine—CYP1A2—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000251	0.00157	CbGpPWpGaD
Cinnarizine—DRD2—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000244	0.00153	CbGpPWpGaD
Cinnarizine—CYP1A2—Biological oxidations—CYP2A7—nicotine dependence	0.000236	0.00148	CbGpPWpGaD
Cinnarizine—CYP1A2—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000233	0.00146	CbGpPWpGaD
Cinnarizine—DRD2—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000226	0.00142	CbGpPWpGaD
Cinnarizine—HRH1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000222	0.00139	CbGpPWpGaD
Cinnarizine—HRH4—GPCR downstream signaling—OPRM1—nicotine dependence	0.000216	0.00135	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—FGD1—nicotine dependence	0.000216	0.00135	CbGpPWpGaD
Cinnarizine—DRD2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000198	0.00124	CbGpPWpGaD
Cinnarizine—HRH4—Signaling by GPCR—OPRM1—nicotine dependence	0.000196	0.00123	CbGpPWpGaD
Cinnarizine—HRH1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000194	0.00122	CbGpPWpGaD
Cinnarizine—DRD2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000194	0.00122	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—AKR1B10—nicotine dependence	0.00019	0.00119	CbGpPWpGaD
Cinnarizine—HRH1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00019	0.00119	CbGpPWpGaD
Cinnarizine—DRD2—Signaling by GPCR—TAS2R16—nicotine dependence	0.00018	0.00113	CbGpPWpGaD
Cinnarizine—HRH1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000176	0.00111	CbGpPWpGaD
Cinnarizine—CACNA1D—Metabolism—CYP2A7—nicotine dependence	0.000173	0.00108	CbGpPWpGaD
Cinnarizine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000161	0.00101	CbGpPWpGaD
Cinnarizine—HRH4—GPCR downstream signaling—DRD2—nicotine dependence	0.000156	0.000978	CbGpPWpGaD
Cinnarizine—DRD2—GPCR downstream signaling—FGD1—nicotine dependence	0.000155	0.000974	CbGpPWpGaD
Cinnarizine—HRH1—GPCR downstream signaling—FGD1—nicotine dependence	0.000152	0.000956	CbGpPWpGaD
Cinnarizine—CACNA1C—Metabolism—CYP2A7—nicotine dependence	0.000152	0.000951	CbGpPWpGaD
Cinnarizine—DRD2—GPCR ligand binding—OPRM1—nicotine dependence	0.000148	0.000926	CbGpPWpGaD
Cinnarizine—HRH1—GPCR ligand binding—OPRM1—nicotine dependence	0.000145	0.000909	CbGpPWpGaD
Cinnarizine—HRH4—Signaling by GPCR—DRD2—nicotine dependence	0.000142	0.000889	CbGpPWpGaD
Cinnarizine—DRD2—Signaling by GPCR—FGD1—nicotine dependence	0.000141	0.000884	CbGpPWpGaD
Cinnarizine—HRH1—Signaling by GPCR—FGD1—nicotine dependence	0.000138	0.000868	CbGpPWpGaD
Cinnarizine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000138	0.000863	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—WASF2—nicotine dependence	0.000134	0.000841	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—WASF1—nicotine dependence	0.000129	0.000806	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—OPRM1—nicotine dependence	0.000116	0.000726	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—TAS2R16—nicotine dependence	0.000106	0.000666	CbGpPWpGaD
Cinnarizine—HRH1—GPCR ligand binding—DRD2—nicotine dependence	0.000105	0.000657	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—TAS2R16—nicotine dependence	0.000104	0.000654	CbGpPWpGaD
Cinnarizine—CYP2A6—Metabolism—CYP2A7—nicotine dependence	8.51e-05	0.000534	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—DRD2—nicotine dependence	8.37e-05	0.000525	CbGpPWpGaD
Cinnarizine—DRD2—GPCR downstream signaling—OPRM1—nicotine dependence	8.34e-05	0.000523	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—FGD1—nicotine dependence	8.33e-05	0.000522	CbGpPWpGaD
Cinnarizine—HRH1—GPCR downstream signaling—OPRM1—nicotine dependence	8.19e-05	0.000514	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—FGD1—nicotine dependence	8.18e-05	0.000513	CbGpPWpGaD
Cinnarizine—DRD2—Signaling by GPCR—OPRM1—nicotine dependence	7.58e-05	0.000475	CbGpPWpGaD
Cinnarizine—HRH1—Signaling by GPCR—OPRM1—nicotine dependence	7.44e-05	0.000466	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—AKR1B10—nicotine dependence	7.36e-05	0.000461	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—AKR1B10—nicotine dependence	7.23e-05	0.000453	CbGpPWpGaD
Cinnarizine—CYP2B6—Metabolism—CYP2A7—nicotine dependence	6.87e-05	0.000431	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism—CYP2A7—nicotine dependence	6.34e-05	0.000398	CbGpPWpGaD
Cinnarizine—HRH1—GPCR downstream signaling—DRD2—nicotine dependence	5.92e-05	0.000371	CbGpPWpGaD
Cinnarizine—HRH1—Signaling by GPCR—DRD2—nicotine dependence	5.38e-05	0.000337	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—WASF2—nicotine dependence	5.19e-05	0.000325	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—WASF2—nicotine dependence	5.09e-05	0.000319	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—WASF1—nicotine dependence	4.97e-05	0.000312	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—WASF1—nicotine dependence	4.88e-05	0.000306	CbGpPWpGaD
Cinnarizine—CYP2D6—Metabolism—CYP2A7—nicotine dependence	4.77e-05	0.000299	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism—CYP2A7—nicotine dependence	4.73e-05	0.000297	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—OPRM1—nicotine dependence	4.48e-05	0.000281	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—OPRM1—nicotine dependence	4.39e-05	0.000276	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—CYP2A7—nicotine dependence	4.04e-05	0.000253	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—DRD2—nicotine dependence	3.18e-05	0.000199	CbGpPWpGaD
